Perspective Therapeutics, Inc. — Director's Dealing 2022

Dec 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2022-12-01

Reporting Person: Hunt Jonathan Robert (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-01	Common Stock	P	53204	$0.3809	Acquired	159510	Direct
2022-12-05	Common Stock	P	32200	$0.38	Acquired	191710	Direct